| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |